Clinical Trial Update: Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing two HIV regimens that include one of two forms of didanosine (ddI) in HIV-infected participants; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Videx (didanosine)
• Videx EC (didanosine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | Phase 3 | Status: COMPLETED